| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |